Josiah K. Halm, M.D., M.S., FACP, FHM, CMQ
Department of Hospital Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Chair, Department of Hospital Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Professor, Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2003 | Medical College of Wisconsin, Milwaukee, Wisconsin, US, Clinical Epidemiology, M.S |
| 1996 | University of Ghana Medical School, Accra, GH, Medicine, MB.chB |
Postgraduate Training
| 2014-2016 | Certificate Program in the Section of Integrated Ethics, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2006-2006 | 32nd Epidemiology and Prevention of Cardiovascular Disease, American Heart Association, Tahoe City, CA |
| 2001-2003 | Primary Care Research & Faculty Development, Medical College of Wisconsin, Milwaukee, Wisconsin |
| 1998-2001 | Residency, Internal Medicine, Cook County Hospital, Chicago, Illinois |
| 1996-1997 | Housemanship, Internal Medicine & Ob/Gyn, Korle-bu Teaching Hospital, Accra |
Licenses & Certifications
| 2024 | Advanced Cardiovascular Life Support |
| 2024 | Basic Life Support |
| 2021 | Controlled Substance Registration Certificate |
| 2013 | The American Board of Medical Quality |
| 2008 | Texas Medical Board Physician License |
| 2007 | Georgia State Medical License |
| 2007 | California State Medical License |
| 2006 | New York State Medical License |
| 2001 | Wisconsin State Medical License |
| 2001 | Diplomat, American Board of Internal Medicine (ABIM) |
| 2001 | American Board of Internal Medicine |
| 1998 | Illinois State Medical License |
Experience & Service
Faculty Academic Appointments
Department Chair ad interim, Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2024
Professor, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2020
Associate Professor, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2020
Clinical Specialist, Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2020
Assistant Professor, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2014
Administrative Appointments/Responsibilities
Associate Director, Department of Faculty Diversity, Equity & Inclusion, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2021
Clinical Medical Director, Clinical Decision Unit (CDU), The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2015
Director of Hospitalist Program, Aurora Sinai Medical Center, Milwaukee, WI, 2005 - 2008
Other Professional Positions
Ad-interim Patient Safety Quality Officer, The University of Texas MD Anderson Cancer Center, Houston, TX, 2025 - 2025
Adjunct Associate Professor, Department of Medicine, Baylor College of Medicine, Volunteer Clinical Faculty, Houston, TX, 2015 - 2016
Section Chief, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2020
Hypertension Consultant, Point-One Software Company, WI, 2006 - 2007
Clinical Assistant Professor of Medicine, University of Wisconsin School of Medicine & Public Health, Milwaukee Clinical Campus, Milwaukee, WI, 2003 - 2008
Clinical Instructor of Medicine, Medical College of Wisconsin & Froedtert Memorial Lutheran Hospital, Milwaukee, WI, 2001 - 2003
Extramural Institutional Committee Activities
Member, Clinical Faculty Review Committee (CFRS), The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Provider Communications Advisory Board, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Faculty DEI Committee, The University of Texas MD Anderson Cancer Center, 2021 - 2023
Member (ex-officio), Committee on Faculty Awards, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Cost of Care Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Hospital at Home Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Divisional Representative, Physician Referral Services (PRS) Executive Council, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Institutional Pain Metrics Workgroup, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Institutional CV Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Africa Committee Member, Global Academic Programs, The University of Texas MD Anderson Cancer Center, 2016 - Present
Member, Institutional Patient Safety Committee, The University of Texas MD Anderson Cancer Center, 2015 - Present
Alternate Member, Accreditation Alternatives Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2014
Member, Clinical Effectiveness Committee - CE Subcommittee, The University of Texas MD Anderson Cancer Center, 2013 - Present
Member, Clinical Effectiveness Committee, Order Sets Task Force, The University of Texas MD Anderson Cancer Center, 2013 - Present
Member, Clinical Effectiveness Committee, Venous Thromboembolism (VTE) Treatment Algorithm Subcommittee, The University of Texas MD Anderson Cancer Center, 2013 - Present
Member, Clinical Effectiveness Committee, Venous Thromboembolism (VTE) Prophylaxis Algorithm and Order Set Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present
Alternate Member for Department Chair, Acute and Critical Care Services Subcommittee, The University of Texas MD Anderson Cancer Center, 2013 - 2015
Member, Sepsis Operational Priority Initiative, The University of Texas MD Anderson Cancer Center, 2012 - Present
Member, Admissions Review Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present
Member, Quality Improvement Assessment Board (QIAB), The University of Texas MD Anderson Cancer Center, 2011
Member, Ongoing Professional Practice Evaluation/Focus Professional Practice Evaluation (OPPE/FPPE) Quality Officers, The University of Texas MD Anderson Cancer Center, 2010 - Present
Member, Division of Internal Medicine Quality Council, The University of Texas MD Anderson Cancer Center, 2009 - Present
Editorial Activities
Clinical Vignettes for Society of General Internal Medicine Annual Meeting, Journal of General Internal Medicine, 2002
Honors & Awards
| 2023 | LEADing Teams Core Curriculum Coursework Completion Graduate, Sponsored by MD Anderson Leadership Institute, June 2023 |
Professional Memberships
Selected Presentations & Talks
International Presentations
- 2025. Leveraging the ECHO (Extension for Community Healthcare Outcomes) Model to Improve Collaboration in Cancer Care: Impact, Innovations, and Future Directions in Africa. Invited. The Residency Training Collaboration Teams (RTCT), US.
Formal Peers
- 2020. Demonstrating Value: Oncology –“ Association of Reduced cost and Improved Quality with Implementation of a Value and Outcomes Driven Oncology-Hospitalist Collaboration”. Invited. Longview, TX, US.
- 2020. Medical Management of Oncology Patients Hospitalized Under Hospitalist Service. Visiting. Tyler, TX, US.
- 2019. Human Factors Engineering and Patient Safety. Invited. The Woodlands, TX, US.
- 2019. Capturing the full value of an Onco-Hospital Program - MD Anderson Experience Ten Year Review. Visiting. Toronto, CA.
- 2019. Role of Oncology-Hospitalist in the delivery of value based medical care for the hospitalized cancer patient. Visiting. Accra, GH.
- 2018. 4th Edition, World Congress of Cancer Survivorship. Invited. Moscow, RU.
- 2016. Quality Improvement - Developing a Quality Management Program for Hospitals in Ghana. Visiting. Accra, GH.
- 2015. Patient Safety - A framework for understanding, measuring and monitoring for safety in Ghana. Visiting. Accra, GH.
- 2012. Affordable Care Act. Invited. Houston, TX, US.
Grant & Contract Support
| Date: | 2015 - 2017 |
| Title: | Derivation and Validation of a Readmission Risk Scoring System in Cancer Patients |
| Funding Source: | University of Texas Healthcare and Effectiveness Quality of Care Grants Program |
| Role: | Co-PI |
| ID: | Grant 162291 |
| Date: | 2007 - 2008 |
| Title: | Double Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure [ASCEND-HF] |
| Funding Source: | Aurora Sinai Medical Center |
| Role: | PI |
| Date: | 2006 - 2007 |
| Title: | Acute decompensated heart failure registry - Adhere® Emergency Module: A multi-center open label observational study |
| Funding Source: | Aurora Sinai Medical Center |
| Role: | PI |
| Title: | Developing a model to enhance emotional wellbeing in adult oncology - NIH Grant #13086045, The University of Texas MD Anderson Cancer Center |
| Funding Source: | NIH |
| Role: | PI |
| ID: | Application No: 4430715 |
| Title: | External Validation of the Covid 19 Risk in Oncology Evaluation Tool |
| Funding Source: | CORONET validation |
| Role: | Collaborator |
| Title: | Implementation of Digital Vital Sign Monitoring to Decrease Sleep Interruption and Enhance Recovery in Phase II of the Promoting Sleep |
| Funding Source: | Patient Engagement and Recovery (PROSPER) Project |
| Role: | Collaborator |
| Title: | The TEXAS Project: Transitions Explored and Studied: Leveraging Data to Prevent Readmissions in the TMC |
| Funding Source: | TMC Health Policy Institute Review Committee |
| Role: | Co-PI |
| Title: | Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Covid 19 Related Acute Respiratory Distress Syndrome |
| Funding Source: | IND# 19950 |
| Role: | Collaborator |
| ID: | Phase I/II Protocol IRB 2020-0365 |
| Title: | Expanded Access to Convalescent Plasma for the Treatment of Patients with Covid 19 |
| Funding Source: | |
| Role: | Collaborator |
| Title: | A Phase I study to Evaluate the Safety of Dose Escalation of Compound Kushen Injection (ZD023) in Lung/Head and Neck Patients receiving Stereotactic Body Radiation Therapy |
| Funding Source: | |
| Role: | Collaborator |
| ID: | Protocol 2021-000 |
| Title: | Pul0942 in Reducing Infection Rate Progression to Covid 19. A Phase 2 Multiple Dose study to Evaluate the Efficacy and Safety of Uul0942 Inhalation Solution in Reducing the Infection Rate and Progression to Covid 19 in Adults Exposed to SAR CoV 2 |
| Funding Source: | IND# 148628 |
| Role: | Collaborator |
| ID: | IRB ID#2020-0407 |
Selected Publications
Peer-Reviewed Articles
- Arthur, JA, Reddy, AS, Popat, UR, Halm, J, Vaughan-Adams, N, Myers, AL, Yang, P, De Moraes, AR, Laureano, R, Lopez-Quinones, I, Urbauer, D, Hui, D, Bruera, E. Abuse potential and analgesic efficacy of intravenous hydromorphone bolus administration among hospitalized patients with cancer pain. Cancer 131(3), 2025. e-Pub 2025. PMID: 39865340.
- Simbaqueba Clavijo, CA, Odaro, OE, Gandhi, A, Koom-Dadzie, K, Musaelyan, A, Dickson, KB, Chua, R, Bhise, VR, Amoateng, MD, Tomy, S, Leal Alviarez, DJ, Phyu, EM, Bogdanich, I, Andersen, C, Sheshadri, A, Palaskas, NL, Halm, J, Manzano, JM. Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service. Cancers 17(3), 2025. e-Pub 2025. PMID: 39941771.
- Tanco K, Lopez G, Koyyalagunta L, Fellman B, Halm J, Ignatius J, Bruera E. Comparison of Health Care Providers Attitudes and Beliefs Regarding Medical Marijuana and Cannabidiol in the Management of Pain and Other Symptoms in Cancer Patients. J Palliat Med 26(4):539-543, 2023. e-Pub 2023. PMID: 36576904.
- Manzano JM, Muthu M, Kheder E, Mohammed A, Halm J, Dickson K, Ali N, Leung C, Koom-Dadzie K, Rubio D, Odaro O, Sibille M, Etchegaray M, Wilson K, Lin H, George M. Hospitalization characteristics and outcomes of patients with cancer and COVID-19 at a comprehensive cancer center. Support Care Cancer 30(9):7783-7788, 2022. e-Pub 2022. PMID: 35705751.
Abstracts
- Escalante C, Zalpour A, Song J, Richardson M, Halm J, Yusuf S, S, Gao. Adverse Events of Rivaroxaban Usage in Cancer Patients. Internal Conference on Thrombosis & Hemostasis, Bergamo, Italy:S220-S221.
- Halm JK. Hospitalization Outcomes Among Patients with Confirmed and Suspected Covid 19 - D# CODE.
- Halm J. AKI and Clinical Outcomes on Cancer Patient with Normal Renal Function and Prior CKD who Acquired Covid 19 Infection. ASCO 2021.
- Manzano, F, Halm, J, et al. Evaluating the Impact of Oncology-Hospitalist Model of Inpatient Care on Unplanned 30-Day Readmissions Among Patients with Lung Cancer. 2017 NCCN 22nd Annual Conference, Orlando, FL.
Book Chapters
- Gonzalez, C, Halm J. Constipation in Cancer Patients. In: Oncologic Emergency Medicine. Springer Science.
- Halm J. Chapter 5: Acute Gastro-Intestinal Bleeding. In: Oncologic Emergencies. Springer Science.
Patient Reviews
CV information above last modified December 04, 2025